Stay updated on Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial

Sign up to get notified when there's something new on the Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page now displays the NCT03132675 study record for tavo plus pembrolizumab in advanced melanoma, including its design, eligibility criteria, locations, outcomes, and record details.
    Difference
    73%
    Check dated 2026-11-08T01:57:20.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T22:03:20.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide banner announces the NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T22:23:30.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T22:24:47.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T22:21:02.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study details, signaling an access restriction to the record. The Home link remains visible in the header/footer, but the main content is replaced by the error page.
    Difference
    0.5%
    Check dated 2026-09-26T22:04:09.000Z thumbnail image

Stay in the know with updates to Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial page.